In May, Canada became the first country in the G7 to approve a generic semaglutide injection, intended for type 2 diabetes patients but can be prescribed off-label for weight loss
This is because the medication is typically started at a lower dose and increased slowly over several weeks
Serious adverse events requiring immediate medical attention include: Pancreatitis: Severe abdominal pain, sometimes radiating to the back, with or without vomiting Gallbladder disease: Right upper quadrant pain, nausea, vomiting Acute kidney injury: Decreased urine output, swelling, fatigue Thyroid C-cell tumors (boxed warning for tirzepatide): Neck mass, difficulty swallowing, persistent hoarseness Metabolic considerations include the risk of hypoglycemia, particularly in patients with type 2 diabetes taking other glucose-lowering medications
Once properly reconstituted with bacteriostatic water or sterile water, the resulting solution should be clear and colorless with no visible particles
Push the air into the vial to help draw medication smoothly